Outlook Therapeutics, Inc.
OTLK · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | – | -$20,153 | -$46,357 | $17,378 |
| Dep. & Amort. | – | $29 | $29 | $29 |
| Deferred Tax | – | $0 | $0 | $0 |
| Stock-Based Comp. | – | $1,682 | $1,723 | $3,672 |
| Change in WC | – | $2,185 | -$5,923 | $6,889 |
| Other Non-Cash | – | $4,354 | $33,944 | -$38,936 |
| Operating Cash Flow | – | -$11,901 | -$16,584 | -$10,967 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | – | -$0 | $0 | $0 |
| Net Acquisitions | – | $0 | $0 | $0 |
| Inv. Purchases | – | $0 | $0 | $0 |
| Inv. Sales/Matur. | – | $0 | $0 | $0 |
| Other Inv. Act. | – | $0 | $0 | $0 |
| Investing Cash Flow | – | -$0 | $0 | $0 |
| Financing Activities | – | – | – | – |
| Debt Repay. | – | -$907 | $190 | $0 |
| Stock Issued | – | $14,153 | $1,416 | $1,742 |
| Stock Repurch. | – | $0 | $0 | $0 |
| Dividends Paid | – | $0 | $0 | $0 |
| Other Fin. Act. | – | $0 | $16,831 | $0 |
| Financing Cash Flow | – | $13,246 | $18,437 | $1,742 |
| Forex Effect | – | $0 | $0 | $0 |
| Net Chg. in Cash | – | $1,345 | $1,854 | -$9,225 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | – | $7,556 | $5,703 | $14,928 |
| End Cash | – | $8,901 | $7,556 | $5,703 |
| Free Cash Flow | – | -$11,901 | -$16,584 | -$10,967 |